Cleveland Clinic researchers are presenting final Phase I data from their novel study of a vaccine aimed at preventing triple-negative breast cancer, the most aggressive and lethal form of the disease.
from Medical Xpress - latest medical and health news stories https://ift.tt/V2YWI83
